Advances in Fertility Preserving Surgery for Borderline Ovarian Tumors

Author(s):  
Mingdan Wang ◽  
Kuiran liu
2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Peng Wang ◽  
Lei Fang

Abstract Background To compare the postoperative recurrence and fertility in patients with borderline ovarian tumors (BOTs) who underwent different surgical procedures: salpingo-oophorectomy versus cystectomy. Methods Potentially relevant literature from inception to Nov. 06, 2020, were retrieved in databases including Cochrane Library, EMBASE (Ovid), and MEDLINE (Pubmed). We applied the keywords “fertility-sparing surgery,” or “conservative surgery,” or “cystectomy,” or “salpingo-oophorectomy,” or “oophorectomy,” or “adnexectomy,” or “borderline ovarian tumor” for literate searching. Systemic reviews and meta-analyses were performed on the postoperative recurrence rates and pregnancy rates between patients receiving the two different surgical methods. Begger’s methods, Egger’s methods, and funnel plot were used to evaluate the publication bias. Result Among the sixteen eligible studies, the risk of recurrence was evaluated in all studies, and eight studies assessed the postoperative pregnancy rates in the BOT patients. A total of 1839 cases with borderline ovarian tumors were included, in which 697 patients (37.9%) received unilateral salpingo-oophorectomy and 1142 patients (62.1%) underwent unilateral/bilateral cystectomy. Meta-analyses showed that BOT patients with unilateral/bilateral cystectomy had significantly higher recurrence risk (OR=2.02, 95% CI: 1.59-2.57) compared with those receiving unilateral salpingo-oophorectomy. Pooled analysis of four studies further confirmed the higher risk of recurrence in patients with cystectomy (HR=2.00, 95% CI: 1.11-3.58). In addition, no significant difference in postoperative pregnancy rate was found between patients with the two different surgical procedures (OR=0.92, 95% CI: 0.60-1.42). Conclusion Compared with the unilateral/bilateral cystectomy, the unilateral salpingo-oophorectomy significantly reduces the risk of postoperative recurrence in patients with BOT, and it does not reduce the pregnancy of patients after surgery. Trial registration PROSPERO CRD42021238177


2007 ◽  
Vol 23 (7) ◽  
pp. 373-376 ◽  
Author(s):  
Maite Cusidó ◽  
Rafael Fábregas ◽  
Pere Barris S ◽  
Cecilia Escayola ◽  
Pere Nolsac Barri

2016 ◽  
Author(s):  
Punita Bhardwaj ◽  
T. K. Das ◽  
S. Batra ◽  

Borderline Ovarian tumors are tumors of uncertain malignant potential. They have favour able prognosis. They occur in younger women and present at an early stage. They are difficult to diagnose preoperatively as macroscopic picture is a combination of benign and invasive ovarian tumors. Over the years surgical treatment has changed from radical to conservative approach without overlooking oncologic safety. Follows up is essential. Prolonged follow up (>10 yrs) is required because of later recurrences. Special attention is to be paid to the conserved ovary in follow up.


1985 ◽  
Vol 66 (4) ◽  
pp. 303-303
Author(s):  
Z. V. Mavlyutova ◽  
S. L. Galeeva

It is known that borderline ovarian tumors have not all signs of malignancy, but they are able to implant in the peritoneum.


2000 ◽  
Vol 77 (2) ◽  
pp. 343-344 ◽  
Author(s):  
Gamal H. Eltabbakh ◽  
Alka Srivastava ◽  
Lynda Lee Garafano

2017 ◽  
Vol 96 (11) ◽  
pp. 1300-1306 ◽  
Author(s):  
Limor Helpman ◽  
Assaf Yaniv ◽  
Mario E. Beiner ◽  
Sarit Aviel-Ronen ◽  
Tamar Perri ◽  
...  

1970 ◽  
Vol 1 (1) ◽  
Author(s):  
Chen Ming

Borderline ovarian tumors belong to a kind of epithelial ovarian tumors, nature between benign and malignant, the incidence of ovarian tumors accounted for 4.0% to 14.0%, clinical manifestations and malignant have a greater similarity,will be transferred, and can recurrence[1]. For the disease,most of the clinical treatment will be given, in recent years,after the completion of surgical treatment, our hospital also on such patients with chemotherapy[2]. In this study, 32 patients were divided into two groups, one group received surgery,chemotherapy, a group of patients undergoing surgery alone,the research process and the results reported in the study of the results of the combination of surgery and chemotherapy in the treatment of borderline ovarian tumors as follows.


Sign in / Sign up

Export Citation Format

Share Document